Ebola virus: Vaccines, survivors and molecular epidemiology
Please arrive 5 minutes before the start of the seminar to gain entrance
The 2013-2016 West African Ebola virus outbreak had devastating effects on the local region. However, the large number of Ebola virus disease cases has allowed researchers to assess; the efficacy of novel vaccines, characteristics of naturally acquired immunity and the existence of sub-symptomatic infections. Additionally, as it was the most extensively sequenced outbreak in history it has provided opportunities to assess virus mutation patterns and develop tools to support molecular epidemiology. The seminar will include an overview of a unique longitudinal analysis of two cohorts of survivors in Guinea and compare naturally acquired and vaccine induced immunity. Aspects of the utility of real-time field sequencing of EBOV in an outbreak setting will also be described.
Date: 23 October 2019, 12:00 (Wednesday, 2nd week, Michaelmas 2019)
Venue: Biology Mansfield Road, 11a Mansfield Road OX1 3SZ
Venue Details: Seminar room
Speaker: Miles Carroll (Public Health England)
Organising department: Nuffield Department of Clinical Medicine
Organiser: Suki Kenth (University of Oxford)
Organiser contact email address: suki.kenth@ndm.ox.ac.uk
Host: Prof. Paul Klenerman (Peter Medawar Building, NDM, Oxford)
Part of: Peter Medawar Building Seminars
Booking required?: Not required
Audience: Members of the University only
Editor: Suki Kenth